Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions…
| Price | $1.97 |
|---|---|
| Market cap | $100.89M |
| Sector | Real Estate |
| Industry | Real Estate - Services |
| Exchange | NYSE |
| 52-week range | 1.12-3.96 |
| Beta | 0.35 |
Explore RFL's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.